{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T09:00:00Z","timestamp":1793350800438,"version":"4.5.0"},"reference-count":59,"publisher":"American Association for the Advancement of Science (AAAS)","issue":"10","license":[{"start":{"date-parts":[[2020,3,4]],"date-time":"2020-03-04T00:00:00Z","timestamp":1583280000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["U01 AI 078045"],"award-info":[{"award-number":["U01 AI 078045"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Sci. Adv."],"published-print":{"date-parts":[[2020,3,6]]},"abstract":"<jats:p>Temperature-stable dissolving film eliminates cold-chain storage and successfully immunizes mice sublingually and buccally.<\/jats:p>","DOI":"10.1126\/sciadv.aau4819","type":"journal-article","created":{"date-parts":[[2020,3,4]],"date-time":"2020-03-04T19:15:12Z","timestamp":1583349312000},"source":"Crossref","is-referenced-by-count":82,"title":["Novel technology for storage and distribution of live vaccines and other biological medicines at ambient temperature"],"prefix":"10.1126","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5066-2673","authenticated-orcid":true,"given":"Irnela","family":"Bajrovic","sequence":"first","affiliation":[{"name":"Division of Molecular Pharmaceutics and Drug Delivery, College of Pharmacy, The University of Texas at Austin, Austin, TX 78712, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen C.","family":"Schafer","sequence":"additional","affiliation":[{"name":"Division of Molecular Pharmaceutics and Drug Delivery, College of Pharmacy, The University of Texas at Austin, Austin, TX 78712, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dwight K.","family":"Romanovicz","sequence":"additional","affiliation":[{"name":"Institute for Cellular and Molecular Biology, College of Natural Sciences, The University of Texas at Austin, Austin, TX 78712, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0809-901X","authenticated-orcid":true,"given":"Maria A.","family":"Croyle","sequence":"additional","affiliation":[{"name":"Division of Molecular Pharmaceutics and Drug Delivery, College of Pharmacy, The University of Texas at Austin, Austin, TX 78712, USA."},{"name":"LaMontagne Center for Infectious Disease, The University of Texas at Austin, Austin, TX 78712, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"221","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1098\/rstb.2013.0433"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp1113569"},{"key":"e_1_3_2_4_2","unstructured":"World Health Organization The top 10 causes of death: Leading causes of death by economy income group (January 2018); http:\/\/www.who.int\/mediacentre\/factsheets\/fs310\/en\/index1.html [accessed 30 August 2019]."},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2016.10.078"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.copbio.2016.03.002"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jix657"},{"key":"e_1_3_2_8_2","first-page":"49","article-title":"Research ethics governance in times of Ebola","volume":"10","author":"Schopper D.","year":"2017","unstructured":"D. Schopper, R. Ravinetto, L. Schwartz, E. Kamaara, S. Sheel, M. J. Segelid, A. Ahmad, A. Dawson, J. Singh, A. Jesani, R. Upshur, Research ethics governance in times of Ebola. Public Health Ethics 10, 49\u201361 (2017).","journal-title":"Public Health Ethics"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2018.1434463"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/civ1013"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2017.06.003"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2016.11.097"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2014.12.037"},{"key":"e_1_3_2_14_2","doi-asserted-by":"crossref","unstructured":"D. R. Feikin B. Flannery M. J. Hamel M. Stack P. M. Hansen Vaccines for Children in Low- and Middle-Income Countries in Reproductive Maternal Newborn and Child Health: Disease Control Priorities Third Edition (Volume 2) R. E. Black R. Laxminarayan M. Temmerman N. Walker Eds. (The International Bank for Reconstruction and Development\/The World Bank Washington DC 2016) pp. 187\u2013205.","DOI":"10.1596\/978-1-4648-0348-2_ch10"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2016.08.045"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1017\/dmp.2016.195"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13104-015-1257-y"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13104-018-3362-1"},{"key":"e_1_3_2_19_2","doi-asserted-by":"crossref","unstructured":"M. Y. Chan T. S. Dutil R. M. Kramer Lyophilization of adjuvanted vaccines: Methods for formulation of a thermostable freeze-dried product in Vaccine Adjuvants: Methods and Protocols C. B. Fox Ed. (Springer New York 2017) pp. 215\u2013226.","DOI":"10.1007\/978-1-4939-6445-1_15"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.gt.3301527"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.4149\/av_2017_301"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2012.06.087"},{"key":"e_1_3_2_23_2","unstructured":"World Health Organization (WHO) Summary of WHO position papers\u2014Recommendations for routine immunization (WHO Geneva) April 2018 update; http:\/\/www.who.int\/immunization\/policy\/Immunization_routine_table1.pdf?ua=1 [accessed 30 August 2019]."},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1097\/NHH.0000000000000371"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.puhe.2017.02.020"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2016.02.014"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrd.2017.251"},{"key":"e_1_3_2_28_2","first-page":"207","article-title":"New horizons in the development of novel needle-free immunization strategies to increase vaccination efficacy","volume":"398","author":"Schulze K.","year":"2016","unstructured":"K. Schulze, T. Ebensen, P. Riese, B. Prochnow, C.-M. Lehr, C. A. Guzm\u00e1n, New horizons in the development of novel needle-free immunization strategies to increase vaccination efficacy. Curr. Top. Microbiol. Immunol. 398, 207\u2013234 (2016).","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"e_1_3_2_29_2","unstructured":"World Health Organization International Travel and Health. Chapter 6. Vaccine-Preventable Diseases and Vaccines. 2017 Update (WHO Press Geneva Switzerland) pp. 80\u2013140."},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1021\/mp5006454"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1021\/mp500646d"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2013.11.033"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms13520"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1089\/10430340050111368"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1111\/1541-4337.12269"},{"key":"e_1_3_2_36_2","first-page":"621","article-title":"Characteristics of four new human cell lines derived from squamous cell carcinomas of the head and neck","volume":"75","author":"Rupniak H. T.","year":"1985","unstructured":"H. T. Rupniak, C. Rowlatt, E. B. Lane, J. G. Steele, L. K. Trejdosiewicz, B. Laskiewicz, S. Povey, B. T. Hill, Characteristics of four new human cell lines derived from squamous cell carcinomas of the head and neck. J. Natl. Cancer Inst. 75, 621\u2013635 (1985).","journal-title":"J. Natl. Cancer Inst."},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2016.10.057"},{"key":"e_1_3_2_38_2","unstructured":"World Health Organization How to Calculate Vaccine Volumes and Cold Chain Capacity Requirements (WHO Press Geneva Switzerland 2017)."},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(15)00266-2"},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.02757-15"},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2010.12.059"},{"key":"e_1_3_2_42_2","first-page":"471","article-title":"Influenza pathogenesis in genetically defined resistant and susceptible murine strain","volume":"90","author":"Samet S. J.","year":"2017","unstructured":"S. J. Samet, S. M. Tompkins, Influenza pathogenesis in genetically defined resistant and susceptible murine strain. Yale J. Biol. Med. 90, 471\u2013479 (2017).","journal-title":"Yale J. Biol. Med."},{"key":"e_1_3_2_43_2","doi-asserted-by":"publisher","DOI":"10.5731\/pdajpst.2015.006155"},{"key":"e_1_3_2_44_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.foodchem.2015.12.067"},{"key":"e_1_3_2_45_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.coph.2017.07.011"},{"key":"e_1_3_2_46_2","first-page":"129","article-title":"An overview of polymeric dosage forms in buccal drug delivery: State of art, design of formulations and their in vivo performance evaluation","volume":"86","author":"Fonseca-Santos B.","year":"2018","unstructured":"B. Fonseca-Santos, M. Chorilli, An overview of polymeric dosage forms in buccal drug delivery: State of art, design of formulations and their in vivo performance evaluation. Korean J. Couns. Psychother. 86, 129\u2013143 (2018).","journal-title":"Korean J. Couns. Psychother."},{"key":"e_1_3_2_47_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2016.09.070"},{"key":"e_1_3_2_48_2","doi-asserted-by":"publisher","DOI":"10.1002\/jps.20157"},{"key":"e_1_3_2_49_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2009.12.025"},{"key":"e_1_3_2_50_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-37481-y"},{"key":"e_1_3_2_51_2","unstructured":"World Health Organization Expert Committee on Specifications for Pharmaceutical Preparations Fifty Second Report on Stability Testing of Active Pharmaceutical Ingredients and Finished Pharmaceutical Products WHO Technical Report Series Report No.: 1010 Geneva Switzerland (2018) pp. 309\u2013351."},{"key":"e_1_3_2_52_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00484-015-1019-5"},{"key":"e_1_3_2_53_2","doi-asserted-by":"publisher","DOI":"10.1641\/0006-3568(2000)050[0109:SMIHDS]2.3.CO;2"},{"key":"e_1_3_2_54_2","doi-asserted-by":"publisher","DOI":"10.1002\/jps.20617"},{"key":"e_1_3_2_55_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1011082911917"},{"key":"e_1_3_2_56_2","doi-asserted-by":"publisher","DOI":"10.3390\/polym3041972"},{"key":"e_1_3_2_57_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.carbpol.2018.02.085"},{"key":"e_1_3_2_58_2","doi-asserted-by":"publisher","DOI":"10.1080\/08927022.2017.1350663"},{"key":"e_1_3_2_59_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.85.24.9396"},{"key":"e_1_3_2_60_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2005.07.019"}],"container-title":["Science Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1126\/sciadv.aau4819","content-type":"unspecified","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/www.science.org\/doi\/pdf\/10.1126\/sciadv.aau4819","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,9]],"date-time":"2024-01-09T15:09:32Z","timestamp":1704812972000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.science.org\/doi\/10.1126\/sciadv.aau4819"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,6]]},"references-count":59,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020,3,6]]}},"alternative-id":["10.1126\/sciadv.aau4819"],"URL":"https:\/\/doi.org\/10.1126\/sciadv.aau4819","relation":{},"ISSN":["2375-2548"],"issn-type":[{"value":"2375-2548","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,6]]},"article-number":"eaau4819"}}